BDX logo

Becton Dickinson and Company (BDX)

$200.89

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on BDX

Market cap

$57.34B

EPS

5.82

P/E ratio

36.5

Price to sales

2.67

Dividend yield

2.091%

Beta

0.274221

Price on BDX

Previous close

$200.43

Today's open

$200.47

Day's range

$198.40 - $202.75

52 week range

$162.29 - $251.99

Profile about BDX

CEO

Thomas E. Polen

Employees

74000

Headquarters

Franklin Lakes, NJ

Exchange

New York Stock Exchange

Shares outstanding

285418551

Issue type

Common Stock

BDX industries and sectors

Healthcare

Medical Equipment & Supplies

News on BDX

BD Stock Up Post Tie-Up to Expand Hazardous Drug Contamination Testing

BDX teams up with ChemoGLO to expand hazardous drug testing, aiming to boost safety in healthcare environments.

news source

Zacks Investment Research • Dec 5, 2025

news preview

BD and ChemoGLO™ Collaborate to Expand Hazardous Drug Contamination Testing for Health Care Facilities and Laboratories

FRANKLIN LAKES, N.J. , Dec. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and ChemoGLO™, a specialist in hazardous drug detection and decontamination, today announced a strategic collaboration to advance hazardous drug contamination testing in health care settings to improve the safety of health care workers.

news source

PRNewsWire • Dec 4, 2025

news preview

BD Launches New Cell Analyzer Configurations to Bring Cutting-Edge Capabilities to Labs of All Sizes

Three- and Four-Laser BD FACSDiscover™ A8 Cell Analyzers Expand Accessibility of Spectral, Real-Time Imaging Cell Analysis FRANKLIN LAKES, N.J. , Dec. 3, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global commercial release of new configurations of cell analyzers featuring breakthrough spectral and real-time cell imaging technologies, enabling more labs in academia, pharma and biotech – across scales, needs and budgets – to advance discoveries in immunology, cancer immunotherapy and cell biology.

news source

PRNewsWire • Dec 3, 2025

news preview

Best Dividend Aristocrats For December 2025

The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed the SPDR S&P 500 ETF (SPY) year-to-date, but November shows a reversal. Several Dividend Aristocrats, including CAH, CAT, CHRW, and ALB, have posted double-digit gains in 2025, while others lag behind. Dividend growth among Aristocrats averages 5.46% for 2025, with most constituents announcing increases, though growth is slightly below 2024 levels.

news source

Seeking Alpha • Nov 29, 2025

news preview

Here's Why Becton Dickinson (BDX) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

news source

Zacks Investment Research • Nov 25, 2025

news preview

BD Surgiphor™ Surgical Wound Irrigation System Expands to Europe to Help Hospitals Improve Patient Safety

FRANKLIN LAKES, N.J. , Nov. 24, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD Surgiphor™ Surgical Wound Irrigation System in Europe.

news source

PRNewsWire • Nov 24, 2025

news preview

BD Onclarity™ HPV Assay for BD COR™ and BD Viper™ LT Systems Receive WHO Prequalification

RANKLIN LAKES, N.J., Nov. 17, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the Conformité Européenne (CE) Marked BD Onclarity™ HPV Assay for the BD COR™ System and the BD Viper™ LT System have been accepted for the World Health Organization (WHO) list of prequalified in vitro diagnostic products, further expanding access to high-quality cervical cancer screening tools in low- and middle-income countries.

news source

PRNewsWire • Nov 17, 2025

news preview

BD Appoints Robert Huffines and Jacqueline Wright to Board of Directors

FRANKLIN LAKES, N.J. , Nov. 17, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Robert "Robbie" Huffines and Jacqueline "Jacky" Wright to its board of directors, effective Dec. 1, 2025.

news source

PRNewsWire • Nov 17, 2025

news preview

Duncan Regional Hospital Becomes First in U.S. to Implement BD Alaris™ EMR Infusion Interoperability with MEDITECH

FRANKLIN LAKES, N.J. , Nov. 13, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Duncan Regional Hospital ("DRH Health") has become the first hospital in the United States to implement BD Alaris™ EMR (Electronic Medical Record) Interoperability with the MEDITECH electronic health record (EHR), marking a significant advancement in patient safety, workflow efficiency and clinician support.

news source

PRNewsWire • Nov 13, 2025

news preview

BDX Unveils Portable PureWick System for On-the-Go Incontinence Care

BD expands its PureWick line with a portable system built for discreet, mobile incontinence care, aiming to deepen its home-care reach.

news source

Zacks Investment Research • Nov 13, 2025

news preview

¹ Disclosures

Get started with M1

Invest in Becton Dickinson and Company

Open an M1 investment account to buy and sell Becton Dickinson and Company commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in BDX on M1